| Literature DB >> 29775669 |
Arti Vashist1, Ajeet Kaushik2, Atul Vashist3, Jyoti Bala2, Roozbeh Nikkhah-Moshaie2, Vidya Sagar2, Madhavan Nair4.
Abstract
Hydrogel-based drug delivery systems (DDSs) have versatile applications such, as tissue engineering, scaffolds, drug delivery, and regenerative medicines. The drawback of higher size and poor stability in such DDSs are being addressed by developing nano-sized hydrogel particles, known as nanogels, to achieve the desired biocompatibility and encapsulation efficiency for better efficacy than conventional bulk hydrogels. In this review, we describe advances in the development of nanogels and their promotion as nanocarriers to deliver therapeutic agents to the central nervous system (CNS). We also discuss the challenges, possible solutions, and future prospects for the use of nanogel-based DDSs for CNS therapies.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29775669 PMCID: PMC6598698 DOI: 10.1016/j.drudis.2018.05.018
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851